Finland· FI-REL-REL42608

Apoquel

A oclacitinib product containing oclacitinib maleate, registered in Finland by Zoetis Belgium. The same ATC class is registered in 2 of our 19 countries.

ATC QD11AH90

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedApoquelATCQD11AH90REGISTER NO.FI-REL-REL42608PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Oclacitinib maleate is registered in 2 of 19 countries.

Countries holding a registration under ATC QD11AH90 (oclacitinib), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Oclacitinib maleate · ATC QD11AH90

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Oclacitinib maleate
Manufacturer
Zoetis Belgium
Country
Finland (FI)
ATC code
QD11AH90
ATC class
Oclacitinib
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Oclacitinib maleate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oclacitinib maleate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba508f89-7eeb-483c-8429-48dbb8a33c89
GET /v1/drugs/ba508f89-7eeb-483c-8429-48dbb8a33c89?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": null,
  "strength": "3.6 mg",
  "atc_label": "Oclacitinib",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/13/154/001-002, 007, 010-011, 019-021",
  "fimea_rel_id": "REL42608",
  "authorised_at": "2013-09-12"
}

See everything about oclacitinib maleate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.